Empire State Development key facts
- Empire State Development is a other based in New York, New York with 16 tracked portfolio companies.
- Notable positions include Glyphic Biotechnologies, Envisagenics, Excelsior Sciences.
- The team roster lists 9 people.
About Empire State Development
Founded in 1995, Empire State Development is a government entity based in New York, New York. The firm focuses on economic development in New York State. The firm seeks to invest in climate technology, health technology, life sciences, agriculture technology systems, advanced manufacturing, software as a service(SaaS), and artificial intelligence sectors.
Empire State Development portfolio at a glance
16 portfolio companies are on record for Empire State Development, including Glyphic Biotechnologies, Envisagenics and Excelsior Sciences.
11 of the 16 carry a recorded valuation.
Empire State Development team
9 people are on record at Empire State Development: 2 partners, 2 board members and 5 others. Senior names include Jonathan Greene (Senior Director), Kevin Law (Executive Vice President) and Hilda Escher (Board Member). 9 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 16 recorded positions
- ·Watchlist + alerts for Empire State Development's activity
Portfolio
16 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Glyphic Biotechnologies | — | ▮ | ▮ | ▮ |
| Envisagenics | — | ▮ | ▮ | ▮ |
| Excelsior Sciences | — | ▮ | ▮ | ▮ |
+ 13 more companies · all 16, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Empire State Development
- What companies does Empire State Development invest in?
- Empire State Development has 16 recorded portfolio companies, including Glyphic Biotechnologies, Envisagenics, Excelsior Sciences.